Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Michael Salgaller Insider Profile
4 Followers
Michael Salgaller, Vice-President at Northwest Biotherapeutics, holds 200.00 shares in Northwest Biotherapeutics (Ticker: NWBO). Most recently, Michael Salgaller ― shares of Northwest Biotherapeutics on ― for an estimated value of ―.
Michael Salgaller has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Michael Salgaller's holdings
Insider Roles
Vice-President
Roles that Michael Salgaller holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Michael Salgaller
Michael Salgaller's Trading History
List of latest transactions for each holding click on a transaction to see Michael Salgaller's performance on stock
You May Also Like
Michael Salgaller insider profile FAQ
What is the percentage of profitable transactions made by Michael Salgaller?
The percentage of profitable transactions made by Michael Salgaller is ―.
What is the average return per transaction made by Michael Salgaller?
The average return per transaction made by Michael Salgaller is ―.
What stocks does Michael Salgaller hold?
Michael Salgaller holds: NWBO stocks.
What was Michael Salgaller’s latest transaction?
Michael Salgaller latest transaction was an Uninformative Buy of ―.
What was Michael Salgaller's most profitable transaction?
Michael Salgaller’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Michael Salgaller's role in Northwest Biotherapeutics?
Michael Salgaller's role in Northwest Biotherapeutics is Vice-President.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.